Voy at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Voy brings 6 presentations to ObesityWeek 2026 in National Harbor. Its program centres on predicting who responds to GLP-1 therapy in real-world use. Topics include baseline and early weight-loss predictors of results at twelve months, the uneven benefit of tirzepatide versus semaglutide, and the cost-effectiveness of tirzepatide paired with digital support.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
UK online weight-loss service that pairs prescribed GLP-1 medication with an app and clinical coaching. | Poster Sat Nov 14 7:30pm–8:30pm Precision Medicine for GLP-1 Therapy, Heterogeneous Benefit of Tirzepatide Vs Semaglutide Chronic disease and obesity complicationsObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm Maximum Early-Period Weight Loss (Months 1–3) Predicts 12‑Month GLP‑1 Response in a Real-World Cohort Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Baseline Predictors of 12-Month Real-World Weight Loss on GLP-1 Therapy: 143,343 Adults Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Predictors of 12-Month Weight Loss with Tirzepatide: A Real-World Study of 88,538 Adults Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Cost-effectiveness of Tirzepatide plus Digital Support for Obesity: Real-World Microsimulation Model Interventional and clinical studies Talk Mon Nov 16 10:10am–10:15am Maximum Early-Period Weight Loss (Months 1–3) Predicts 12-Month GLP-1 Response in a Real-World Cohort Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyPolicy and public health |
Find decision makers at Voy
Tell us what you sell and we’ll find the people at Voy most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction